Managing Intellectual Property

Pfizer acts against Chinese fakes

22 May 2004

Pharmaceutical company Pfizer is to train Chinese officials on ways to spot fake medicines in an effort to tackle the country’s growing counterfeit drug problem

Pharmaceutical company Pfizer is to train Chinese officials on ways to spot fake medicines in an effort to tackle the country's growing counterfeit drug problem.

Pfizer last week signed a memorandum of understanding with the Shanghai Municipal Food and Drug Administration to provide medicines safety training to agency staff. The company signed a similar agreement in December 2003 with the Shanghai Administration for Industry...



Only subscribers have complete access to Managing IP Magazine, log in or subscribe now.

Alternatively take a free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).

Subscribe Now

This article is available to subscribers. Please click subscribe to read the rest of the article.

Subscribe

Take a free trial

Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.

Take a free trial


February 2012

Patent survey 2012

Managing IP ranks the leading patent firms around the world



Most read articles

Poll

Will the new post grant and inter partes review proceedings result in more litigators practising pro hac vice before the USPTO?







Supplements